International medtech competition review
This article was originally published in The Gray Sheet
Executive Summary
The International Trade Commission, at the request of the House Ways & Means Committee, has launched a general fact-finding investigation regarding the competitive conditions affecting U.S. sales and trade of medical devices in principal foreign markets, according to an April 3 release. Japan is highlighted as a market of particular interest, following a hearing held by the committee in September in which the country's regulatory policies on medical technology were criticized as a "non-tariff barrier" (1"The Gray Sheet" Oct. 3, 2005, p. 11). The ITC will examine the most recent five-year period for which data are available, and must provide a report to the committee by March 9, 2007. In addition, the commission will hold a public hearing on the subject July 11...
You may also be interested in...
Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry
Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.